Literature Update: Audit Proofing Mohs Notes
Dr. Ted Rosen discusses a recent paper with specific guidance on avoiding audits and reimbursement denials for Mohs micrographic surgery. Reducing Mohs Micrographic Surgery Reimbursement Issues By Ted Rosen, MD, FAADEditor-in-Chief Payers, including Medicare, suspect that Mohs micrographic surgery (MMS) is overused in clinical practice to increase compensation. Furthermore, denying payment for “inappropriate” use of […]
Literature Update : Hidradenitis Suppurativa
Managing Hidradenitis Suppurativa During Pregnancy Dr. Ted Rosen discusses a recent paper updating dermatologists about the nuances of managing hidradenitis suppurativa during pregnancy and post-partum. “Hidradenitis suppurativa (HS) and its management have special nuances should it occur during pregnancy and the postpartum period,” said Dr. Ted Rosen, referring to the paper “Dermatologic Management of Hidradenitis […]
Mounting Evidence Supports Promise of JAK Inhibitor Treatment for Refractory Dermatomyositis
Recent research suggests JAK inhibitors, specifically tofacitinib, may be useful in the management of refractory dermatomyositis. With Ted Rosen, MD, FAAD In 2016, dermatologists from Harvard Medical School published what they described as the first report of the successful use of the Janus kinase (JAK)-1/3 inhibitor, tofacitinib, to treat refractory cutaneous dermatomyositis (DM).1 Based on […]
Microaggression in medicine
With Amy McMichael, MD Microaggressions can be intentional or unintentional slights, insults, or indignities on diversity-defining characteristics, such as race, gender, and religion. Verbal or nonverbal, they are not always obvious to others. “I experience microaggression still today, but one of the times when a microaggression really affected me emotionally was when I was a […]
Topical corticosteroids and the risk of osteoporosis, fractures
Alexander Egeberg, MD, PhD, with Bob Kronemyer Topical corticosteroids (TCSs) are some of the most frequently used drugs for skin diseases worldwide. While these agents are generally considered safe, they are often prescribed with little thought about the dosage or duration. Systemic and inhaled corticosteroids negatively impact bone remodeling and cause osteoporosis and bone fracture […]
Options for regional melanoma
Results from clinical trials published over the past several years are swiftly shaping what some are calling a new paradigm for the treatment of stage III melanoma.